Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Cassava Sciences stock

Learn how to easily invest in Cassava Sciences stock.

Cassava Sciences Inc is a biotechnology business based in the US. Cassava Sciences shares (SAVA) are listed on the NASDAQ and all prices are listed in US Dollars. Cassava Sciences employs 24 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy shares in Cassava Sciences

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – SAVA – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Cassava Sciences stock price (NASDAQ: SAVA)

Use our graph to track the performance of SAVA stocks over time.

Cassava Sciences shares at a glance

Information last updated 2022-06-24.
Latest market close$29.47
52-week range$15.72 - $146.16
50-day moving average $23.98
200-day moving average $41.53
Wall St. target price$72.50
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-1.16

Buy Cassava Sciences shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 6 of 6
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
eToro
Stocks, ETFs, Cryptocurrency
$0
$10
$10
when you sign up and deposit $100
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, or TN.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.
SoFi Invest
Stocks, ETFs, Cryptocurrency
$0
$1
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
Tastyworks
Stocks, Options, ETFs, Cryptocurrency
$0
$0
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0
$0
$125 - $625
when you open and fund an account with $25,000 - $250,000+
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Axos Bank Self Directed Investing
Stocks
$0
$1,000
$150
when you open an account and deposit at least $1500.
Vanguard Personal Advisor
Stocks, Mutual funds, ETFs
$0
$0
N/A
Financial advice powered by relationships, not commissions.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Cassava Sciences stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Cassava Sciences price performance over time

Historical closes compared with the close of $29.47 from 2022-06-28

1 week (2022-06-22) 0.68%
1 month (2022-05-26) 15.57%
3 months (2022-03-25) -26.64%
6 months (2021-12-29) -31.45%
1 year (2021-06-29) -64.48%
2 years (2020-06-29) 850.65%
3 years (2019-06-28) 2,335.54%
5 years (2017-06-29) 617.03%

Cassava Sciences financials

Gross profit TTM $-24,813,000
Return on assets TTM -11.16%
Return on equity TTM -17.9%
Profit margin 0%
Book value $5.92
Market capitalisation $1.2 billion

TTM: trailing 12 months

Cassava Sciences share dividends

We're not expecting Cassava Sciences to pay a dividend over the next 12 months.

Have Cassava Sciences's shares ever split?

Cassava Sciences's shares were split on a 1:7 basis on 9 May 2017. So if you had owned 7 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Cassava Sciences shares – just the quantity. However, indirectly, the new 600% higher share price could have impacted the market appetite for Cassava Sciences shares which in turn could have impacted Cassava Sciences's share price.

Cassava Sciences share price volatility

Over the last 12 months, Cassava Sciences's shares have ranged in value from as little as $15.72 up to $146.16. A popular way to gauge a stock's volatility is its "beta".

SAVA.US volatility(beta: 0.94)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Cassava Sciences's is 0.9383. This would suggest that Cassava Sciences's shares are less volatile than average (for this exchange).

Cassava Sciences overview

Cassava Sciences, Inc. , a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. Cassava Sciences, Inc.

Frequently asked questions

What percentage of Cassava Sciences is owned by insiders or institutions?
Currently 6.79% of Cassava Sciences shares are held by insiders and 26.65% by institutions.
How many people work for Cassava Sciences?
Latest data suggests 24 work at Cassava Sciences.
When does the fiscal year end for Cassava Sciences?
Cassava Sciences's fiscal year ends in December.
Where is Cassava Sciences based?
Cassava Sciences's address is: 7801 North Capital of Texas Highway, Austin, TX, United States, 78731
What is Cassava Sciences's ISIN number?
Cassava Sciences's international securities identification number is: US14817C1071
What is Cassava Sciences's CUSIP number?
Cassava Sciences's Committee on Uniform Securities Identification Procedures number is: 14817C107

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site